Quarterly Financial Information (unaudited) - Additional information (Details) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Sep. 30, 2019 |
Dec. 31, 2018 |
Jun. 30, 2018 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Licensing and other arrangements | ||||||
| Revenue recognized | $ 17,276 | $ 5,068 | ||||
| Rezolute | License Agreement and Common Stock Purchase Agreement | ||||||
| Licensing and other arrangements | ||||||
| Revenue recognized | $ 2,500 | $ 6,000 | $ 1,800 | 14,000 | $ 1,800 | |
| Janssen Biotech Inc. | License Agreement | ||||||
| Licensing and other arrangements | ||||||
| Revenue recognized | $ 2,500 | $ 800 | $ 2,500 | |||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|